What if you could simply provide a urine sample rather than undergo a painful surgical procedure to find out if your cancer was responding to treatment? It may seem too good to be true, but researchers at Pavol Jozef Šafárik University in Košice, Slovakia, have identified fluorescent molecules in urine that may allow patients with malignant melanoma to do just that.
- Neurotic college students could benefit from health education
- New genes for human deafness found in Israeli families
- How a single protein in non-neuronal cells controls brain development
- Mathematics: Modelling the timings of a COVID-19 second wave in Europe
- New materials: A toggle switch for catalysis